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Phospholipase C- (PLC-) is a recently identified
PLC isoform activated by subunits of heterotrimeric G
proteins (G12, G13, and G) as well as by the low
molecular weight GTPases, Rho and Ras. To define the
enzymatic activity and substrate specificity of PLC-
as well as its potential direct activation by Rho family
GTPases, a major fragment of PLC- encompassing the
catalytic core (EF-hand repeats through the tandem
Ras-associating domains; 118 kDa) was purified to
near homogeneity and assayed after reconstitution
under various conditions. Similar to the enzymatic
profiles of previously purified PLC- isozymes, the pu-
rified fragment of PLC- maximally hydrolyzed phos-
phatidylinositol 4-phosphate at a rate of 10 mol/mg
of protein/min, exhibited phospholipase activity de-
pendent on the concentration of free calcium, and
favored phosphatidylinositol 4,5-bisphosphate as sub-
strate relative to other phosphoinositides. Further-
more, in mixed detergent phospholipid micelles, RhoA
stimulated the phospholipase activity of the PLC-
fragment in both a concentration-dependent and
guanosine 5-O-(3-thiotriphosphate)-dependent man-
ner. This activation was abolished by the deletion of a
unique 65 amino acid-insert within the catalytic core
of PLC-. Although Rac1 activated purified PLC-2 in a
guanine nucleotide-dependent manner, Rac1 failed to
promote guanine nucleotide-dependent activation of
purified PLC-. These results indicate that PLC- is a
direct downstream effector for RhoA and that RhoA-
dependent activation of PLC- depends on a unique
insert within the catalytic core of the phospholipase.
Phospholipase C (PLC)1 isozymes respond to a variety of
extracellular signaling molecules to stimulate hydrolysis of
PtdIns(4,5)P2 into the second messengers, inositol(1,4,5)
trisphosphate and diacylglycerol (1). The generation of these
two second messengers triggers the release of intracellular
Ca2 and stimulates protein kinase C isozymes, respectively.
Five different isoforms of PLC have been identified, each with
distinct mechanisms of activation. The PLC- isozymes are
directly activated by heterotrimeric G protein  subunits of the
Gq family (2–4) and by G subunits (5–7). More recently,
these isozymes were shown to be activated by the small
GTPase Rac (8–11). Activation of receptor and cytosolic tyro-
sine kinases promotes activation of PLC- via phosphorylation
and translocation (12–14). The mechanisms by which extracel-
lular stimuli regulate PLC- (15, 16) and the recently identified
PLC- (17, 18) are less understood, although both are believed
to require the mobilization of Ca2.
The fifth family member of PLC isozymes, PLC-, initially
was identified in Caenorhabditis elegans as a Ras-binding pro-
tein (19). Mammalian PLC- subsequently was identified as a
phospholipase C isozyme containing multiple Ras interaction
domains (20–22) including a CDC25 homology domain in the
amino terminus and tandem Ras-associating (RA) domains at
the carboxyl terminus. Coexpression of GTPase-deficient, con-
stitutively active Ras mutants with PLC- results in accumu-
lation of inositol phosphates in COS-7 cells (22). Transient
coexpression with G12, G13 (21, 23), or G (23) also pro-
motes phospholipase activity of PLC-. More recently, a screen
of Rho family GTPases revealed a marked activation of PLC-
when coexpressed with RhoA, RhoB, or RhoC but not with Rac
or Cdc42 (24). This activation depended on a unique 65 res-
idue-insert within the Y box of the catalytic TIM barrel of
PLC-, and co-precipitation studies indicated an interaction
between PLC- and RhoA. Although these results suggest that
PLC- is a direct, downstream effector of Rho GTPases, other
interpretations are also consistent with the data.
To provide incontrovertible evidence for direct activation of
PLC- by GTP-bound Rho GTPases, we overexpressed and pu-
rified a large fragment of the phospholipase (PLC- EF-RA2;
118 kDa) and present here the enzymatic characterization of
this fragment reconstituted with phospholipids and GTPases.
Relative to previously purified PLC isozymes, purified PLC-
EF-RA2 exhibited similar specific phospholipase activity and
phosphoinositide substrate preferences. Moreover, our analy-
ses illustrate direct, guanine nucleotide-dependent activation
of PLC- by RhoA and further implicate the catalytic core of
PLC- as the effector region necessary for RhoA-stimulated
phospholipase activity.
EXPERIMENTAL PROCEDURES
Materials—The open reading frame of rat PLC- was a kind gift from
Grant Kelley (State University of New York, Syracuse, NY). A PLC--
specific antibody was generated by BIOSOURCE against a predicted
exposed sequence (amino acids 1523–1540; LKAHQTPVDILKQ-
KAHQL) directly C-terminal to the X box of the catalytic core. 3H-
Labeled phosphoinositide substrates were prepared from [3H]inositol-
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labeled turkey erythrocytes as described previously (4). His6-tagged
tobacco etch virus protease was purified as described previously (25).
Purification of PLC- EF-RA2—A fragment of PLC- encompassing
approximately one-half of the EF-hand repeats through the second RA
domain (amino acids 1258–2215) was amplified from full-length PLC-
by PCR and subcloned into NcoI/XhoI-digested pFastBacHT, which
incorporates a His6 tag and a tobacco etch virus protease site at the
amino terminus of the expressed enzyme. Baculovirus encoding PLC-
EF-RA2 was generated using the Bac-to-Bac method (Invitrogen).
HighFive insect cells at a density of 2.0  106 cells/ml were infected
with virus encoding PLC- EF-RA2 at a multiplicity of infection of 1.0.
After 48 h of incubation at 27 °C, cells were harvested by low speed
centrifugation and resuspended in 100 ml of buffer A (20 mM HEPES,
pH 8.0, 300 mM NaCl, 1 mM CaCl2, and 10% glycerol) with two EDTA-
free complete protease inhibitor tablets (Roche Applied Science). Cells
were lysed using an EmulsiFlex C5 cell homogenizer (Avestin), and the
lysate was centrifuged at 100,000  g for 45 min. The clarified super-
natant was diluted to a final volume of 150 ml and loaded onto a 5-ml
HighTrap metal chelate column (Amersham Biosciences) charged with
Ni2. Purification steps included a 10-column volume buffer A wash
and a 10-column volume 3% buffer B wash (buffer A  1 M imidazole).
Recombinant protein was eluted with 10 column volumes of 40% buffer
B collected in 5-ml fractions. Fractions containing the recombinant
protein were dialyzed overnight against buffer A in the presence of
His6-tagged tobacco etch virus protease to remove the His6 tag from
PLC- EF-RA2. The cleaved protein was subjected to a second passage
over a Ni2-charged metal chelate column and eluted with 5 mM imid-
azole as a final purification step. Fractions containing the purified
protein were pooled and concentrated using a 50,000 MWCO PES
centrifugal filtering device (Vivascience). The final concentration of the
recombinant protein was determined by comparing a Bradford assay to
bovine serum albumin standards. Purification of avian PLC-t was
described previously (26). PLC-2 PH-C2 is a fragment of full-length
human PLC-2 that encompasses amino acid residues 1–801 and was
purified as described previously (11).
Purification of FLAG-tagged PLC- Constructs—Construction of
mammalian expression vectors for PLC- EF-Ct and PLC- EF-CY
was described previously (24). PLC- EF-Ct spans amino acids 1198–
2281, and PLC- EF-CY spans amino acids 1198–2281 but lacks 62
amino acids (residues 1667–1728) that occur as an 70-amino acid
insert that is conserved in all orthologues of PLC-. COS-7 cells were
seeded on 150-mm dishes at a density of 5.0  106 cells per dish and
maintained in high glucose Dulbecco’s modified Eagle’s medium con-
taining 10% fetal bovine serum, 100 units/ml penicillin, and 10 g/ml
streptomycin at 37 °C in an atmosphere of 90% air, 10% CO2. Sixty
microliters of FuGENE 6 transfection reagent (Roche Applied Science)
was used to transfect 20 g of each PLC- vector construct per dish
according to the manufacturer’s protocol. The overexpressed recombi-
nant PLC isozymes were purified using anti-FLAG M2 affinity gel
according to the manufacturer’s protocol (Sigma). Briefly, 36 h after
transfection, growth medium was removed from the cells, and the
dishes were rinsed with phosphate-buffered saline (10 mM phosphate,
2.7 mM potassium chloride, 137 mM sodium chloride, pH 7.4). After
aspiration of the phosphate-buffered saline, 1 ml of lysis buffer was
added per dish, and the dishes were incubated for 15 min with shaking.
Cells were scraped from dishes, and the lysate was centrifuged at
12,000  g for 10 min. The resultant supernatant was subjected to a
single gravity flow passage over a 1-ml bed volume of anti-FLAG M2
affinity gel and washed with 10 bed volumes of Tris-buffered saline (50
mM Tris, pH 7.5, 150 mM NaCl) to remove unbound proteins. Recombi-
nant protein was then collected in six 500-l elutions with 100 g/ml
FLAG peptide in Tris-buffered saline.
Purification of Small GTPases—The coding sequences of human
monomeric GTPases were amplified by PCR and ligated into BamHI/
XhoI-digested pFastBacHT. Baculovirus encoding the Rho family
GTPases was produced using the Bac-to-Bac system. Recombinant pro-
teins were expressed in HighFive insect cells at a density of 2.0  106
cells/ml after infection with baculovirus at a multiplicity of infection of
1.0. The cells were harvested after 48 h at 27 °C by low speed centrif-
ugation and resuspended in 50 ml of buffer A (20 mM HEPES, pH 8.0,
150 mM NaCl, 1 mM MgCl2, 5% glycerol) with one EDTA-free complete
protease inhibitor tablet. Membranes of virus-infected cells were har-
vested by high speed centrifugation at 100,000  g of the cell lysate for
1 h. Lipidated, membrane-bound GTPases were solubilized by deter-
gent extraction of the harvested membranes in buffer A containing 1%
purified sodium cholate and one EDTA-free complete protease inhibitor
tablet for 1 h at 4 °C. Solubilized membrane proteins were recovered by
centrifugation of the extracted membranes at 100,000  g for 1 h. The
clarified supernatant was diluted with buffer A to achieve a final
detergent concentration of 0.3% and was subsequently loaded onto a
HighTrap metal chelate column charged with Ni2. Recombinant pro-
tein was collected over an imidazole gradient running from 0 to 1 M over
20 column volumes. Fractions containing the recombinant GTPase were
pooled and concentrated using 10,000 MWCO PES centrifugal filtering
device. The concentrations of the individual GTPases were determined
by quantifying the binding of [35S]GTPS under the same buffer con-
ditions used for reconstitution of the GTPases in phospholipid vesicles
described below.
Phospholipase C Assay—Two different procedures were utilized for
measuring phospholipase activity of PLC enzymes. Initial experiments
measuring maximum enzymatic activity were carried out in the pres-
ence of a detergent substrate mixture. The second assay employed
FIG. 1. Purification and functional
activity of PLC- EF-RA2. A, schematic
representation of full-length PLC- (2281
total amino acids, top) and PLC- EF-RA2
(residues 1258–2215, bottom). PLC- EF-
RA2 lacks the amino-terminal cysteine-
rich domain (Cys), CDC25 domain, and
PH domain but retains approximately
half the EF-hand repeats as well as the
catalytic TIM barrel (X and Y regions), C2
domain, and tandem RA domains. B,
PLC- EF-RA2 was purified as described
under “Experimental Procedures,” and fi-
nal samples of recombinant protein were
analyzed by SDS-PAGE using a 4–15%
polyacrylamide gradient. Gels were either
Coomassie-stained (left) or transferred to
nitrocellulose and immunoblotted with an
antibody specific to the X-Y linker region
of PLC- (right). C, the specific activity of
the purified PLC- fragment was meas-
ured using [3H]PtdIns(4)P as substrate in
the presence of 0.5% sodium cholate for 10
min at 30 °C (left) and compared with the
specific activity of purified avian PLC-t
(right).
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phospholipid vesicles combined with purified GTPases in cholate-con-
taining buffers prior to the addition of PLC-. Assays were performed
interchangeably using either [3H]PtdIns(4)P or [3H]PtdIns(4,5)P2 as
substrate as indicated in the figure legends.
Maximum enzymatic activity was determined as previously de-
scribed (4) with minor modification. Briefly, PLC isozymes were incu-
bated in final buffer conditions including 10 mM HEPES, pH 7.4, 120
mM KCl, 10 mM NaCl, 2 mM EGTA, 5.8 mM MgSO4, 0.5% cholate, 100
M free calcium, 0.16 mg/ml fatty acid-free bovine serum albumin, 100
M PtdIns(4)P (Avanti Polar Lipids), and 10,000 cpm/assay
[3H]PtdIns(4)P in a final volume of 60 l. Assays were at 30 °C for 10
min and were terminated by the addition of 200 l of 10% trichloro-
acetic acid and 100 l of 10 mg/ml fatty acid-free bovine serum albumin.
Centrifugation of the reaction mixture separated aqueous
[3H]Ins(1,4)P2 from precipitated [
3H]PtdIns(4)P, and soluble
[3H]Ins(1,4)P2 was quantified by liquid scintillation counting.
Most experiments to determine enzyme characteristics and potential
regulation by small GTPases utilized phosphatidylethanolamine (PE)-
and PtdIns(4,5)P2-containing lipid vesicles in assays that were previ-
ously described (27) with minor modifications. Briefly, recombinant
proteins were presented in lipid vesicles containing 50 M
PtdIns(4,5)P2, 500 M PE (Avanti Polar Lipids), and 10,000 cpm of
[3H]PtdIns(4,5)P2 per assay. Final buffer conditions were 20 mM
HEPES, pH 7.4, 70 mM KCl, 3 mM EGTA, 2 mM dithiothreitol, 0.16
mg/ml fatty acid-free bovine serum albumin, and 1 M free Ca2 in a
final volume of 60 l. The concentration of free calcium was calculated
using WinMAXC software (Stanford University). All reactions were
performed at 25 °C for 10 min after the addition of the indicated PLC
enzyme. Experiments designed to determine the substrate selectivity of
PLC- EF-RA2 utilized 1 nmol each of PtdIns, PtdIns(4)P, and
PtdIns(4,5)P2, along with 30 nmol of PE per assay. Only the
3H-labeled
phosphoinositide substrate was changed for each condition.
For experiments determining the effects of small GTPases on phos-
pholipase activity, 10 l of purified G protein was reconstituted in
phospholipid vesicles, resulting in a final cholate concentration of
0.05%. The small GTPases were loaded with nucleotide by incubation
with 10 M GDP or 10 M GTPS under assay conditions for 20 min at
25 °C prior to the addition of PLC. Assays were initiated by the addition
of PLC enzyme and incubated for 10 min at 25 °C. Reactions were
terminated by the addition of 200 l of 10% trichloroacetic acid and 100
l of 10 mg/ml fatty acid-free bovine serum albumin. [3H]Inositol(1,4,5)
trisphosphate was quantified by liquid scintillation counting of the
soluble fraction after centrifugation of the reaction mixture.
RESULTS
Purification of PLC- EF-RA2—A fragment of PLC- (Fig.
1A) encompassing approximately half the EF-hand repeats
through the second RA domain (amino acids 1258–2215) was
purified after overexpression from a recombinant baculovirus
in HighFive insect cells as described under “Experimental Pro-
cedures.” The soluble fraction of the enzyme bound efficiently
to a metal chelate column as a first purification step. After
tobacco etch virus protease cleavage of the affinity tag, a second
passage over a metal chelate column yielded a nearly homoge-
neous preparation of the recombinant protein (Fig. 1B). The
purified PLC- fragment migrated as a species of 118 kDa on
SDS-PAGE as seen by Coomassie staining and immunoblot
analysis with a PLC--specific antibody. Contaminating pro-
teins observed by Coomassie staining were not immunoreac-
tive, suggesting that the impurities were not breakdown prod-
ucts of the PLC- fragment. The typical yield of purified PLC-
was 0.5–1.0 mg/liter baculovirus-infected insect cells. Multiple
attempts to purify full-length PLC- after insect cell expression
have yielded insufficient amounts of purified protein.
PLC Activity of PLC- EF-RA2—The purified PLC- frag-
ment exhibited phospholipase C activity in assays utilizing a
detergent and lipid mixture containing 50 M [3H]PtdIns(4)P
as substrate (Fig. 1C). Enzymatic activity depended on the
FIG. 2. Characterization of the
phospholipase activity of PLC- EF-
RA2. A, time course of PtdIns(4,5)P2 hy-
drolysis in the presence of PLC- EF-RA2
(10 ng) was tested either in the absence
(open squares) or presence (closed circles)
of 300 nM inactive (GDP-bound) RhoA or
in the presence of activated (GTPS-
bound) RhoA (closed triangles). B, PLC-
EF-RA2 was incubated with phospholipid
vesicles containing [3H]PtdIns(4,5)P2 sub-
strate under varying calcium concen-
trations in the absence of RhoA (open
circles) or presence of 300 nM GTPS-
bound RhoA (closed circles). C, the lipase
activity of PLC- EF-RA2 (2 ng) was as-
sayed with increasing concentrations of
PtdIns(4,5)P2 substrate. The data shown
are the mean  S.E. of three separate
experiments, and the inset is a Hofstee
plot of the data. D, the substrate selectiv-
ity of PLC- EF-RA2 was tested by pres-
entation of either [3H]PtdIns (black bars),
[3H]PtdIns(4)P (dashed bars), or
[3H]PtdIns(4,5)P2 (open bars) with equal
amounts of each cold substrate per assay
as described under “Experimental Proce-
dures.” Enzyme activity was tested with
two different concentrations of the puri-
fied enzyme.
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amount of purified phospholipase and was linear over a range
of concentrations. The observed enzymatic activity of 10
mol/min/mg of protein was similar to that of the widely stud-
ied purified avian PLC-t (4, 6, 28, 29). Subsequent assays
were performed utilizing PE- and PtdIns(4,5)P2-containing
vesicles either in the absence of detergent when examining
PLC- activity alone or in the presence of 0.05% sodium cholate
when reconstituting PLC- with vesicles containing purified
small GTPases. Phosphoinositide hydrolysis was linear for at
least 10 min under the conditions of these assays (Fig. 2A).
Similar to other PLC isozymes, enzymatic activity of PLC-
EF-RA2 depended on the concentration of free calcium with an
EC50 value of 65  11 nM (n  3), and maximum activity was
observed at a concentration of 1 M free Ca2 (Fig. 2B).
Kinetic analyses of PLC- EF-RA2 were performed utilizing
PE- and PtdIns(4,5)P2-containing vesicles presented at various
concentrations in the bulk medium (see “Experimental Proce-
dures”). These experiments and Hofstee analyses revealed a
Vmax of 6.5 mol/min/mg of protein and a Km value for
PtdIns(4,5)P2 of 6.0 M (n  3) (Fig. 2C). The phospholipid
substrate selectivity of PLC- EF-RA2 was determined using
PE- and PtdIns-containing vesicles composed of an equal ratio
of PtdIns:PtdIns(4)P:PtdIns(4,5)P2. The recombinant PLC-
fragment hydrolyzed phosphoinositides with a rank order of
selectivity of PtdIns(4,5)P2  PtdIns(4)P  PtdIns (Fig. 2D).
Activation of Recombinant PLC- by RhoA—Previous studies
indicate that the Rho family members, RhoA, RhoB, and RhoC,
induce stimulation of phospholipase activity when transiently
coexpressed with PLC- in COS-7 cells (24). To determine
whether the stimulation of PLC- by Rho family GTPases is
direct, RhoA was expressed from a recombinant baculovirus in
insect cells, purified to near homogeneity from detergent-ex-
tracted membranes, and reconstituted in substrate-containing
phospholipid vesicles. As illustrated in the time course assay in
Fig. 2A, recombinant RhoA (300 nM) stimulated phospholipase
activity of PLC- by 2.5-fold in the presence of GTPS but had
no effect in the presence of GDP. To further assess this
phenomenon, RhoA was reconstituted over a wide range of
concentrations in mixed detergent phospholipid micelles, and
PtdIns(4,5)P2 hydrolysis was quantified in the presence of the
purified PLC- fragment (Fig. 3). The amount of recombinant
PLC- used (2 ng) for reconstitution with the GTPases was
adjusted to achieve a basal activity of 5–10 pmol/min. RhoA
caused a 2–3-fold stimulation of PLC- in all experiments.
Stimulation was GTPS-dependent, and half-maximal activa-
tion was observed at a concentration of RhoA of 58  18 nM (n 
4). The calcium dependence for activation of PLC- was not
changed in the presence of GTPS-activated RhoA (Fig. 2B).
GTPS-dependent activation of PLC- was not observed with
non-lipidated RhoA purified from bacteria, suggesting that C-
terminal isoprenylation of RhoA may be required for activation
(data not shown).
The selectivity for activation of PLC- by Rho family
GTPases was examined by assessing the potential capacity of
purified Rac1 to activate PLC- following purification of the
lipidated form of the GTPase from baculovirus-infected insect
cells. At relatively high concentrations (300 nM), Rac1 caused
an increase in PLC- activity. However, no guanine nucleo-
tide dependence was observed (Fig. 4). Lower concentrations
of Rac1 also had no effect on PLC- in the absence or presence
of GTPS (data not shown), and the increased activity ob-
served at higher GTPase concentrations may result from
contaminating proteins that accompany the purification. Al-
though Rac1 had no effect on PLC- activity, this Rho family
GTPase caused an 2-fold GTPS-dependent stimulation of
PLC-2 PH-C2 (Fig. 4), which is consistent with previously
published data (8, 10, 11).
Activity of the Unique Y Box Insert of PLC-—Previous tran-
sient expression studies in COS-7 cells indicate that a unique
amino acid insert within the Y box of the catalytic TIM barrel
of PLC- not present in other PLC isozymes is required for
activation of PLC- by Rho, G12, and G13 (24). To further
determine the importance of the Y region insert in PLC-, two
FLAG-tagged fragments of PLC- were purified after overex-
FIG. 3. Activation of PLC- by RhoA. Increasing concentrations of
recombinant RhoA purified from detergent-extracted HighFive insect
cell membranes were reconstituted in phospholipid vesicles as
described under “Experimental Procedures.” Assays included PLC-
EF-RA2 in mixed detergent phospholipid micelles containing
[3H]PtdIns(4,5)P2. After a 20-min preincubation of RhoA with either 10
M GDP (open circles) or 10 M GTPS (closed circles), PLC- EF-RA2
(1–2 ng) was added and the assay was performed for 10 min at 25 °C.
Basal activity of PLC- EF-RA2 in the absence of RhoA (5–15 pmol/min)
was subtracted to give the final values. The results presented are the
mean  S.E. of four individual experiments.
FIG. 4. Stimulation of PLC isozymes by small GTPases. RhoA
and Rac1 were purified from detergent-extracted HighFive insect cell
membranes after expression from recombinant baculoviruses as de-
scribed under “Experimental Procedures.” Inset, purified proteins were
resolved by SDS-PAGE, and gels were stained with Coomassie Blue.
Purified PLC- EF-RA2 (2 ng) or PLC-2 PH-C2 (2 ng) was incubated
with mixed detergent phospholipid micelles reconstituted with 300 nM
monomeric GTPase in the presence of 10 M GDP or 10 M GTPS.
Data are presented as -fold increase of activity observed in the presence
of GTPS after subtraction of the basal PLC activity.
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pression in COS-7 cells (Fig. 5, inset). Both constructs of PLC-
spanned the EF-hand repeats through the C terminus with one
fragment lacking 62 amino acids within the Y box (Fig. 5A).
Analyses of the purified PLC- fragments in the absence of
RhoA indicated that removal of the insert within the Y box
decreased basal enzymatic activity of the enzyme 20-fold.
Therefore, when reconstituted with RhoA-containing vesicles,
the added amount of purified PLC- fragment was normalized
to give a basal lipase activity of 5 pmol/min with each con-
struct. Under these conditions, 300 nM purified RhoA caused an
2-fold stimulation of the PLC- EF-Ct fragment, and this
activation was entirely GTPS-dependent. In contrast, no
GTPS-dependent activation by RhoA was observed with the
PLC- fragment lacking the 62-amino acid Y box insert (Fig.
5B). These data further support in vivo data suggesting that
the Y insert region is necessary for RhoA-dependent activation
of PLC-.
DISCUSSION
The recent identification of PLC- as a downstream effector
of Ras and Rho adds a new level of complexity to phospholipid
signaling involving monomeric GTPases. In this study, we il-
lustrate the direct, GTP-dependent stimulation of PLC- in
phospholipid vesicles reconstituted with purified RhoA. These
data also extend previous in vivo studies in which phospho-
inositide hydrolysis by PLC- promoted by Rho depended on
the presence of a unique 65 amino-acid sequence within the Y
box of the catalytic TIM barrel of PLC-. PLC- lacking this
region retained activation by G or H-Ras in coexpression
experiments in COS-7 cells; however, Rho-, G12-, and G13-
dependent activation was not observed (24).
A subfamily of RhoGEFs (i.e. p115RhoGEF, LARG, PDZ-
RhoGEF) activated by G12 and G13 provides a direct link
between stimulation of G protein-coupled receptors and the
activation of Rho GTPases (30–33). Because deletion of the
unique insert within the Y box of PLC- causes loss of respon-
siveness to Rho, G12, and G13, we hypothesize that activation
of PLC- by G12 and G13 occurs indirectly by promoting Rho
activation. This is supported by the fact that C3 toxin, which
ADP-ribosylates and inactivates Rho, prevented activation of
PLC- by Rho, G12, or G13 and prevented agonist activation
of a lysophosphatidic acid receptor but did not inhibit the
activation of PLC- isozymes by Gq.
2 Direct activation of
PLC- by Rho does not rule out the possibility of direct activa-
tion of PLC- by G12 or G13. However, our combined in vivo
and in vitro data suggest that G12 and G13 mostly likely
activate PLC- indirectly via a subfamily of RhoGEFs typified
by p115RhoGEF.
Although the complete set of determinants within PLC-
required for interaction with Rho have yet to be identified, our
current results combined with previous in vivo data (24) have
unambiguously identified a region within the catalytic core of
PLC- that is necessary for the direct stimulation of the phos-
pholipase activity of PLC- by GTP-bound Rho. Sequence anal-
yses of the catalytic regions of PLC- have not revealed obvious
regions of homology to other known Rho-binding domains (34).
In a similar vein, the PH domain of PLC-2 binds GTP-acti-
vated Rac (11). However, the current experiments directly il-
lustrate that the PH domain of PLC- is not required for acti-
2 M. Hains, M. Wing, and T. K. Harden, unpublished data.
FIG. 5. Loss of Rho-dependent regu-
lation in a PLC- fragment lacking a
conserved insert within the Y box. A,
domain architecture of two PLC- frag-
ments that span the EF-hand repeats
through the carboxyl terminus. Both con-
structs span amino acids 1198–2281;
however, PLC- EF-CY lacks residues
1667–1728 within the Y box (dark region).
B, both PLC- fragments were purified as
described under “Experimental Proce-
dures” and analyzed by SDS-PAGE using
a 4–15% polyacrylamide gradient (inset).
PLC- EF-Ct (1 ng) and PLC- EF-CY
(20 ng) were incubated with detergent
lipid vesicles reconstituted with 300 nM
RhoA in the presence of 10 M GDP (open
bars) or 10 M GTPS (solid bars) using
[3H]PtdIns(4,5)P2 as substrate. The data
are presented as the -fold increase in
phospholipase activity in the presence of
GTPS-bound RhoA over GDP-bound
RhoA after subtraction of basal PLC
activity.
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vation by RhoA. These results suggest that eventual structural
determination of the interface will define a novel mode of
effector modulation by Rho GTPases.
The mechanisms whereby Rho family GTPases activate PLC
isozymes remain a point of conjecture. Our unpublished studies
suggest that prenylation of RhoA is required for stimulation of
PLC- because soluble bacterial RhoA failed to activate PLC-.
GTP-dependent binding of the lipidated GTPase to PLC
isozymes may promote phospholipase activity by causing trans-
location of the lipase to the phospholipid bilayer. However, a
more active role of GTPases may involve conformational
changes in PLC isozymes that enhance phospholipase activity.
Perhaps the strongest case for GTPase-stimulated phospho-
lipase activity occurs with the Rho-promoted activation of
PLC- studied here, whereby binding of Rho within the cata-
lytic core of PLC- is readily envisioned to induce conforma-
tional changes favorable for lipase activity. Cooperative mech-
anisms of Rho-dependent activation of PLC- are also possible,
whereby Rho induces the lipase activity of PLC- through both
spatial and conformational regulation of the enzyme.
The addition of PLC- as a direct effector in Rho-dependent
signaling expands the role of Ras superfamily proteins in
phospholipid signaling and metabolism. Historically, Rho
family GTPases have been studied as regulators of actin dy-
namics, gene transcription, cell cycle progression, and cell ad-
hesion (34). More recently, Rho has been shown to increase
PtdIns(4,5)P2 levels in cells through activation of phosphatidy-
linositol 4-phosphate 5-kinase (35, 36) and to negatively regu-
late diacylglycerol kinase activity (37). Rho may potentiate
inositol lipid signaling by increasing PtdIns(4,5)P2 substrate
levels and increasing PKC activity by inhibition of phosphoryl-
ation of diacylglycerol. PLC- potentially is involved in several
signal transduction pathways involving multiple Ras family
GTPases. The data reported here show PLC- is an effector for
GTP-bound RhoA, and future experiments will more com-
pletely define the binding regions within PLC- and the phys-
iological role played by PLC--dependent pathways in Rho-
activated signaling.
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